Loading…
CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)...
Saved in:
Published in: | Scientific reports 2023-09, Vol.13 (1), p.14401-14401, Article 14401 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4696-1384b2d1c95ec9c0285b843734a4c44b91b88d987c63cc7622b6c47c91cbc56d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4696-1384b2d1c95ec9c0285b843734a4c44b91b88d987c63cc7622b6c47c91cbc56d3 |
container_end_page | 14401 |
container_issue | 1 |
container_start_page | 14401 |
container_title | Scientific reports |
container_volume | 13 |
creator | Dhumale, Pratibha Nielsen, Jakob Vennike Hansen, Anne Cathrine Schmidt Burton, Mark Beck, Hans Christian Jørgensen, Mads Gustaf Toyserkani, Navid Mohamadpour Haahr, Martha Kirstine Hansen, Sabrina Toft Lund, Lars Thomassen, Mads Sørensen, Jens Ahm Andersen, Ditte Caroline Jensen, Charlotte Harken Sheikh, Søren Paludan |
description | Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+ ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31− and parent ADRCs. When CD31+, CD31− and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+ ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+ ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+ ADRCs. |
doi_str_mv | 10.1038/s41598-023-41535-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8349d1f1a861482c933e74589114bbd7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8349d1f1a861482c933e74589114bbd7</doaj_id><sourcerecordid>2860404827</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4696-1384b2d1c95ec9c0285b843734a4c44b91b88d987c63cc7622b6c47c91cbc56d3</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEElXpC7CyxIZNwLc49gqhgUKlSmxgbflykvEoYwc7GcTb19NUlLLAGx_Z3_nPRX_TvCb4HcFMvi-cdEq2mLK2RqxrybPmgmLetZRR-vyv-GVzVcoB19NRxYm6aMbdJ0aQhyFEKMigsto5zetklpAiSgPar0cTkfFhTgVaDzmcwKMMI0TIlToBcjBNBf0Kyx7NaYG4IBPHkCoRHIJhALeUV82LwUwFrh7uy-bH9efvu6_t7bcvN7uPt63jQomWMMkt9cSpDpxymMrOSs56xg13nFtFrJReyd4J5lwvKLXC8d4p4qzrhGeXzc2m65M56DmHo8m_dTJB3z-kPGqTl-Am0JJx5clAjBSES-oUY9DzTipCuLW-r1ofNq15tUfwrk6WzfRE9OlPDHs9ppMmmPe89l4V3j4o5PRzhbLoYyjndZkIaS2aSoE5rsXPxd78gx7SmmPdVaU6VUdlglSKbpTLqZQMw59uCNZnM-jNDLqaQd-bQZ-T2JZUKhxHyI_S_8m6A7ZCtus</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2859762361</pqid></control><display><type>article</type><title>CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Full-Text Journals in Chemistry (Open access)</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Dhumale, Pratibha ; Nielsen, Jakob Vennike ; Hansen, Anne Cathrine Schmidt ; Burton, Mark ; Beck, Hans Christian ; Jørgensen, Mads Gustaf ; Toyserkani, Navid Mohamadpour ; Haahr, Martha Kirstine ; Hansen, Sabrina Toft ; Lund, Lars ; Thomassen, Mads ; Sørensen, Jens Ahm ; Andersen, Ditte Caroline ; Jensen, Charlotte Harken ; Sheikh, Søren Paludan</creator><creatorcontrib>Dhumale, Pratibha ; Nielsen, Jakob Vennike ; Hansen, Anne Cathrine Schmidt ; Burton, Mark ; Beck, Hans Christian ; Jørgensen, Mads Gustaf ; Toyserkani, Navid Mohamadpour ; Haahr, Martha Kirstine ; Hansen, Sabrina Toft ; Lund, Lars ; Thomassen, Mads ; Sørensen, Jens Ahm ; Andersen, Ditte Caroline ; Jensen, Charlotte Harken ; Sheikh, Søren Paludan</creatorcontrib><description>Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+ ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31− and parent ADRCs. When CD31+, CD31− and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+ ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+ ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+ ADRCs.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-023-41535-1</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/532 ; 692/4025 ; 692/699 ; Angiogenesis ; Aorta ; Body fat ; Erectile dysfunction ; Heterogeneity ; Humanities and Social Sciences ; multidisciplinary ; Paracrine signalling ; Plastic surgery ; Progenitor cells ; Proteins ; Regenerative medicine ; Science ; Science (multidisciplinary) ; Stem cells</subject><ispartof>Scientific reports, 2023-09, Vol.13 (1), p.14401-14401, Article 14401</ispartof><rights>The Author(s) 2023</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Springer Nature Limited 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4696-1384b2d1c95ec9c0285b843734a4c44b91b88d987c63cc7622b6c47c91cbc56d3</citedby><cites>FETCH-LOGICAL-c4696-1384b2d1c95ec9c0285b843734a4c44b91b88d987c63cc7622b6c47c91cbc56d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2859762361/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2859762361?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids></links><search><creatorcontrib>Dhumale, Pratibha</creatorcontrib><creatorcontrib>Nielsen, Jakob Vennike</creatorcontrib><creatorcontrib>Hansen, Anne Cathrine Schmidt</creatorcontrib><creatorcontrib>Burton, Mark</creatorcontrib><creatorcontrib>Beck, Hans Christian</creatorcontrib><creatorcontrib>Jørgensen, Mads Gustaf</creatorcontrib><creatorcontrib>Toyserkani, Navid Mohamadpour</creatorcontrib><creatorcontrib>Haahr, Martha Kirstine</creatorcontrib><creatorcontrib>Hansen, Sabrina Toft</creatorcontrib><creatorcontrib>Lund, Lars</creatorcontrib><creatorcontrib>Thomassen, Mads</creatorcontrib><creatorcontrib>Sørensen, Jens Ahm</creatorcontrib><creatorcontrib>Andersen, Ditte Caroline</creatorcontrib><creatorcontrib>Jensen, Charlotte Harken</creatorcontrib><creatorcontrib>Sheikh, Søren Paludan</creatorcontrib><title>CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><description>Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+ ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31− and parent ADRCs. When CD31+, CD31− and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+ ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+ ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+ ADRCs.</description><subject>631/532</subject><subject>692/4025</subject><subject>692/699</subject><subject>Angiogenesis</subject><subject>Aorta</subject><subject>Body fat</subject><subject>Erectile dysfunction</subject><subject>Heterogeneity</subject><subject>Humanities and Social Sciences</subject><subject>multidisciplinary</subject><subject>Paracrine signalling</subject><subject>Plastic surgery</subject><subject>Progenitor cells</subject><subject>Proteins</subject><subject>Regenerative medicine</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Stem cells</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstu1DAUhiMEElXpC7CyxIZNwLc49gqhgUKlSmxgbflykvEoYwc7GcTb19NUlLLAGx_Z3_nPRX_TvCb4HcFMvi-cdEq2mLK2RqxrybPmgmLetZRR-vyv-GVzVcoB19NRxYm6aMbdJ0aQhyFEKMigsto5zetklpAiSgPar0cTkfFhTgVaDzmcwKMMI0TIlToBcjBNBf0Kyx7NaYG4IBPHkCoRHIJhALeUV82LwUwFrh7uy-bH9efvu6_t7bcvN7uPt63jQomWMMkt9cSpDpxymMrOSs56xg13nFtFrJReyd4J5lwvKLXC8d4p4qzrhGeXzc2m65M56DmHo8m_dTJB3z-kPGqTl-Am0JJx5clAjBSES-oUY9DzTipCuLW-r1ofNq15tUfwrk6WzfRE9OlPDHs9ppMmmPe89l4V3j4o5PRzhbLoYyjndZkIaS2aSoE5rsXPxd78gx7SmmPdVaU6VUdlglSKbpTLqZQMw59uCNZnM-jNDLqaQd-bQZ-T2JZUKhxHyI_S_8m6A7ZCtus</recordid><startdate>20230901</startdate><enddate>20230901</enddate><creator>Dhumale, Pratibha</creator><creator>Nielsen, Jakob Vennike</creator><creator>Hansen, Anne Cathrine Schmidt</creator><creator>Burton, Mark</creator><creator>Beck, Hans Christian</creator><creator>Jørgensen, Mads Gustaf</creator><creator>Toyserkani, Navid Mohamadpour</creator><creator>Haahr, Martha Kirstine</creator><creator>Hansen, Sabrina Toft</creator><creator>Lund, Lars</creator><creator>Thomassen, Mads</creator><creator>Sørensen, Jens Ahm</creator><creator>Andersen, Ditte Caroline</creator><creator>Jensen, Charlotte Harken</creator><creator>Sheikh, Søren Paludan</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230901</creationdate><title>CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects</title><author>Dhumale, Pratibha ; Nielsen, Jakob Vennike ; Hansen, Anne Cathrine Schmidt ; Burton, Mark ; Beck, Hans Christian ; Jørgensen, Mads Gustaf ; Toyserkani, Navid Mohamadpour ; Haahr, Martha Kirstine ; Hansen, Sabrina Toft ; Lund, Lars ; Thomassen, Mads ; Sørensen, Jens Ahm ; Andersen, Ditte Caroline ; Jensen, Charlotte Harken ; Sheikh, Søren Paludan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4696-1384b2d1c95ec9c0285b843734a4c44b91b88d987c63cc7622b6c47c91cbc56d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>631/532</topic><topic>692/4025</topic><topic>692/699</topic><topic>Angiogenesis</topic><topic>Aorta</topic><topic>Body fat</topic><topic>Erectile dysfunction</topic><topic>Heterogeneity</topic><topic>Humanities and Social Sciences</topic><topic>multidisciplinary</topic><topic>Paracrine signalling</topic><topic>Plastic surgery</topic><topic>Progenitor cells</topic><topic>Proteins</topic><topic>Regenerative medicine</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Stem cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dhumale, Pratibha</creatorcontrib><creatorcontrib>Nielsen, Jakob Vennike</creatorcontrib><creatorcontrib>Hansen, Anne Cathrine Schmidt</creatorcontrib><creatorcontrib>Burton, Mark</creatorcontrib><creatorcontrib>Beck, Hans Christian</creatorcontrib><creatorcontrib>Jørgensen, Mads Gustaf</creatorcontrib><creatorcontrib>Toyserkani, Navid Mohamadpour</creatorcontrib><creatorcontrib>Haahr, Martha Kirstine</creatorcontrib><creatorcontrib>Hansen, Sabrina Toft</creatorcontrib><creatorcontrib>Lund, Lars</creatorcontrib><creatorcontrib>Thomassen, Mads</creatorcontrib><creatorcontrib>Sørensen, Jens Ahm</creatorcontrib><creatorcontrib>Andersen, Ditte Caroline</creatorcontrib><creatorcontrib>Jensen, Charlotte Harken</creatorcontrib><creatorcontrib>Sheikh, Søren Paludan</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dhumale, Pratibha</au><au>Nielsen, Jakob Vennike</au><au>Hansen, Anne Cathrine Schmidt</au><au>Burton, Mark</au><au>Beck, Hans Christian</au><au>Jørgensen, Mads Gustaf</au><au>Toyserkani, Navid Mohamadpour</au><au>Haahr, Martha Kirstine</au><au>Hansen, Sabrina Toft</au><au>Lund, Lars</au><au>Thomassen, Mads</au><au>Sørensen, Jens Ahm</au><au>Andersen, Ditte Caroline</au><au>Jensen, Charlotte Harken</au><au>Sheikh, Søren Paludan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><date>2023-09-01</date><risdate>2023</risdate><volume>13</volume><issue>1</issue><spage>14401</spage><epage>14401</epage><pages>14401-14401</pages><artnum>14401</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+ ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31− and parent ADRCs. When CD31+, CD31− and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+ ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+ ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+ ADRCs.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/s41598-023-41535-1</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2023-09, Vol.13 (1), p.14401-14401, Article 14401 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_8349d1f1a861482c933e74589114bbd7 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Full-Text Journals in Chemistry (Open access); PubMed Central; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 631/532 692/4025 692/699 Angiogenesis Aorta Body fat Erectile dysfunction Heterogeneity Humanities and Social Sciences multidisciplinary Paracrine signalling Plastic surgery Progenitor cells Proteins Regenerative medicine Science Science (multidisciplinary) Stem cells |
title | CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A14%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD31%20defines%20a%20subpopulation%20of%20human%20adipose-derived%20regenerative%20cells%20with%20potent%20angiogenic%20effects&rft.jtitle=Scientific%20reports&rft.au=Dhumale,%20Pratibha&rft.date=2023-09-01&rft.volume=13&rft.issue=1&rft.spage=14401&rft.epage=14401&rft.pages=14401-14401&rft.artnum=14401&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-023-41535-1&rft_dat=%3Cproquest_doaj_%3E2860404827%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4696-1384b2d1c95ec9c0285b843734a4c44b91b88d987c63cc7622b6c47c91cbc56d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2859762361&rft_id=info:pmid/&rfr_iscdi=true |